Oscar Health, INC Form 4 insider transactions

Oscar Health Director Jeffery H. Boyd acquired 3,106 deferred stock units in lieu of cash retainer payments for board service, increasing his beneficial ownership to 66,248 units.

Oscar Health Director William Gassen elected to receive deferred stock units in lieu of cash for board service, increasing his beneficial ownership.

Oscar Health, Inc. Director David Plouffe elected to receive 1,257 deferred stock units in lieu of cash retainer payments for his board service, aligning his interests further with shareholders.

Oscar Health's President of Technology and CTO, Mario Schlosser, sold 23,038 shares of Class A Common Stock for $17.65 per share under a pre-arranged trading plan.

Oscar Health's President of Technology and CTO, Mario Schlosser, sold 76,962 shares of Class A Common Stock for $17.01 per share under a pre-arranged trading plan.

Oscar Health's President of Technology and CTO, Mario Schlosser, reported the sale of 234,861 shares of Class A common stock in early January 2026, executed under a Rule 10b5-1 trading plan.

Oscar Health's President of Technology & CTO, Mario Schlosser, sold 38,835 shares of Class A Common Stock for approximately $15.00 per share.

Oscar Health's Chief Legal Officer, Adam McAnaney, sold 1,852 shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.

Oscar Health's President of Technology & CTO, Mario Schlosser, sold 23,965 shares of Class A Common Stock to cover tax withholding obligations.

Oscar Health's President, Janet Liang, sold 7,338 shares of Class A Common Stock at a weighted average price of $16.59 per share to cover tax obligations from vested equity awards.

Oscar Health's CFO, Richard Scott Blackley, sold 25,135 shares of Class A Common Stock for tax withholding purposes.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, sold 4,149 shares of Class A Common Stock to cover tax withholding obligations from equity award vesting.

Oscar Health's President of Technology and CTO, Mario Schlosser, reported the exercise of stock options and subsequent sale of Class A common stock to cover costs and tax obligations.

Oscar Health Director William Gassen acquired 1,004 deferred stock units valued at $20.54 each in lieu of cash for his board service.

Oscar Health Director David Plouffe elected to receive 1,034 deferred stock units in lieu of cash for board service, increasing his beneficial ownership.

Oscar Health Director Jeffery H. Boyd acquired 2,555 deferred stock units on October 9, 2025, as part of his compensation election, increasing his total beneficial ownership to 63,142 units.

Oscar Health's President of Technology & CTO, Mario Schlosser, exercised stock options and sold a portion of Class A common stock to cover exercise costs and tax obligations.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, disposed of 6,266 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Oscar Health's Chief Financial Officer, Richard Scott Blackley, disposed of 28,166 Class A Common Stock shares to cover tax withholding obligations related to RSU vesting.

Oscar Health's President of Oscar Insurance, Janet Liang, disposed of 7,303 Class A Common Stock shares to cover tax withholding obligations related to RSU vesting.

Oscar Health's Chief Legal Officer, Adam McAnaney, disposed of 1,845 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Oscar Health's President of Technology & CTO, Mario Schlosser, disposed of 23,879 Class A common shares to cover tax withholding obligations related to RSU vesting.

Oscar Health, Inc. Director David Plouffe acquired 1,368 deferred stock units on July 10, 2025, as compensation for his board service, bringing his total beneficial ownership to 3,102 units.

Oscar Health, Inc. Director William Gassen acquired 1,215 deferred stock units on July 10, 2025, in lieu of cash compensation for his board service, increasing his beneficial ownership to 2,745 units.

Oscar Health, Inc. Director Jeffery H. Boyd elected to receive 3,380 deferred stock units valued at $15.53 per unit in lieu of cash for board service, increasing his beneficial ownership.

Oscar Health, Inc. Director Jeffery H. Boyd was granted 14,134 restricted stock units (RSUs) on June 4, 2025, increasing his beneficial ownership to 705,673 shares of Class A Common Stock.

Oscar Health, Inc. Director Laura W. Lang was granted 14,134 Class A Common Stock Restricted Stock Units (RSUs) on June 4, 2025, increasing her beneficial ownership to 74,365 shares.

Oscar Health, Inc. Director David Plouffe has reported the acquisition of 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025, increasing his total beneficial ownership to 128,646 shares.

Oscar Health, Inc. Director Sid Sankaran has acquired 14,134 Class A Common Stock shares through a restricted stock unit (RSU) grant, increasing his direct beneficial ownership.

Oscar Health, Inc. Director Vanessa Ames Wittman was granted 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025, increasing her direct beneficial ownership to 128,646 shares.